Hussein recommends a basic immunohistochemical panel including CD45 (for lymphoid malignancies), AE1/AE3 pankeratins (for most carcinomas), S100 (melanomas), and CD34 (vascular neoplasms and leukemias). This evidence concerns the gene SLC4A1 and melanoma.